Tag: RADIOENHANCERS
SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 37TH ANNUAL MEETING: NANOBIOTIX PRESENTS UPDATED PHASE 1 DATA ON COMBINATION OF NBTXR3 WITH ANTI-PD-1, WHICH MAY SUPPORT RADIOENHANCER’S IMMUNE SYSTEM-BOOSTING POTENTIAL – 10 /11/2022 at 08:30
These data will be discussed during the conference call presenting Nanobiotix’s third quarter results, at 8 a.m. EST / 2 p.m. CET. • Data from the entire dose escalation part…